Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

SAN CARLOS, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2010.

Cash, cash equivalents, and short-term investments at September 30, 2010 were $303.3 million as compared to $396.2 million at December 31, 2009.

Revenue for the third quarter of 2010 increased to $37.9 million as compared to $10.2 million in the third quarter of 2009.  The increase in revenue year over year is largely the result of the amortization of the $125 million milestone payment received from AstraZeneca in September 2009 under the partnership agreement for NKTR-118.  

Total operating costs and expenses in the third quarter of 2010 were $44.2 million compared to $39.1 million in the third quarter 2009. The increase in total operating costs and expenses was primarily due to an increase in research and development expenses.

Research and development expenses were $27.7 million and increased by 20% in the third quarter of 2010 as compared to $23.0 million for the same quarter in 2009.  General and administrative expense increased slightly to $10.2 million in the third quarter 2010 from $9.9 million in the third quarter of 2009.

“Nektar’s continued productivity in research and development has resulted in a deep pipeline of programs that range from those in preclinical research to those preparing for Phase 3,” said Howard W. Robin, President and Chief Executive Officer of Nektar.  “With our Phase 2 data this year from our exciting oncology candidate, NKTR-102, and the preclinical data from our new opioid candidate, NKTR-181, we continue to demonstrate the value of Nektar’s proprietary polymer conjugate technology.”

Net loss for the third quarter ended September 30, 2010 decreased to $8.7 million or $0.09 per share
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter 2014 financial results after the Nasdaq market closes ... a live conference call and webcast to discuss its ... August 7, 2014 at 8:00 a.m. Eastern Time (5:00 ... live conference call by dialing 866-952-1907 (US) or 785-424-1826 ...
(Date:7/29/2014)... , July 29, 2014  Sysmex America, Inc., a ... systems technology, will feature an exhibit booth during the ... and Clinical Lab Expo in Chicago ... "We are extremely excited to exhibit at ... interact with our customers and continue the dialogue on ...
(Date:7/29/2014)... Apex Medical Corporation (Apex, TWSE: 4106), a leading ... announces that it is appealing the judgment of the Regional ... Germany that found the headgear of certain mask ... initiated invalidity challenges against various ResMed patents in major countries. ... and junk patents. ResMed filed the lawsuit ...
Breaking Medicine Technology:Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3Apex Continues Fighting Against Patents to Free Up Competition 2
... and BASEL, Switzerland, Nov. 15, 2010 Dalton ... created to provide clients with geographically diversified, fully ... of active pharmaceutical ingredients. In order ... efficiency, pharmaceutical development companies have been seeking Chemistry ...
... Nov. 12, 2010 Nephros, Inc. (OTC Bulletin Board: ... and marketing filtration products for therapeutic applications, infection control, ... three months ended September 30, 2010. ... prior year period. Reduced loss from operations by ...
Cached Medicine Technology:Dalton and Lonza Announce Co-operation to Provide Contract Chemistry Services and Manufacturing 2Dalton and Lonza Announce Co-operation to Provide Contract Chemistry Services and Manufacturing 3Nephros Reports 2010 Third Quarter Financial Results 2Nephros Reports 2010 Third Quarter Financial Results 3Nephros Reports 2010 Third Quarter Financial Results 4Nephros Reports 2010 Third Quarter Financial Results 5Nephros Reports 2010 Third Quarter Financial Results 6
(Date:7/30/2014)... 2014 According to the Yeast Infection No ... comprehensive guide that will help candida sufferers get rid of ... This book uncovers to readers the truth about yeast infection ... this book, people will discover natural and safe remedies to ... itching, burning, and irritation of the vagina or vulva. ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 The San ... J. Helbock A.P.C. are announcing that they are now offering ... negative effects of asbestos exposure. , “Symptoms of asbestos ... exposed to the toxin 30 plus years ago may just ... Founder of The Law Office of Melinda J. Helbock A.P.C. ...
(Date:7/29/2014)... New York, NY (PRWEB) July 30, 2014 ... profile European fertility centers have been added to the ... Positivity continues to develop out of joint efforts — ... Cyprus create an initiative to offer affordable, state-of-the-art, and ... fertility clinics begins with a comprehensive study by ...
(Date:7/29/2014)... July 29, 2014 1Heart Caregiver ... communities with focus on Brain Fitness Education brings ... Ventura. Brain Fitness Program Director Tee Barr delivered ... Memory Care unit and the Assisted Living section ... Life Enrichment Director Christy Rozsa and Aegis Life ...
(Date:7/29/2014)... say they have discovered a chemical alteration in a ... confirmed in larger studies, could give doctors a simple ... attempting suicide. , The discovery, described online in ... in a gene involved in the function of the ... in turning what might otherwise be an unremarkable reaction ...
Breaking Medicine News(10 mins):Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3
... More than 25 children have died of suspected encephalitis and ... Muzaffarpur district for the past few days //. ... the spread of the killer disease. The children reported sudden ... bouts of unconsciousness and convulsion leading to their death. ...
... clinical symptoms like depression, anxiety, suicidal thoughts and other ... in their body image than others - a study ... ,Dr. Jennifer Dyl of Brown Medical School in ... conscious with their body shape and weight are likely ...
... Mayo Clinic, Rochester, Minnesota has revealed that obesity was ... for the Hepatitis C virus (HCV). ,Lead ... found that obese patients treated for the chronic hepatitis ... better results when underlying abnormalities caused by excessive fat ...
... Europe threatens the public health systems leading to fall ... in the fertility-related studies and clinics performing assisted conception, ... said Paul Devroey, the chairman of the European Society ... more fertility organizations and policies related to development of ...
... tried to analyze the many reasons why some teen girls ... IVF treatments //. In his reading, they are just going ... ridiculed. ,Laurence Shaw, the deputy medical director of ... opinion that, it is the internal program charted by nature ...
... bane in the health policy of Britain. Experts arguably explain ... //marked or hurting it becomes difficult to identify and to ... an epidemic one in six people at some point of ... to warrant medical treatment. ,Though this is a ...
Cached Medicine News:Health News:Depression Could Quickly Grow Into UK’s Biggest Proble 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: